Table 1.
Distribution of undiagnosed and diagnosed participants in three trajectories over sex and HLA.
| Undiagnosed | Diagnosed | ||||||
|---|---|---|---|---|---|---|---|
| TR1(n = 483) | TR2 (n = 257) |
TR3 (n = 762) |
TR1 (n = 256) |
TR2 (n = 273) |
TR3 (n = 114) |
||
| Sex | Male | 283 (59%) | 145 (56%) | 409 (54%) | 155 (61%) | 146 (53%) | 52 (46%) |
| Female | 200 (41%) | 112 (44%) | 353 (46%) | 101 (39%) | 127 (47%) | 62 (54%) | |
| HLA-DR status | DR3/4 | 73 (15%) | 48 (19%) | 141 (19%) | 93 (36%) | 106 (39%) | 41 (36%) |
| DR4/X | 298 (62%) | 140 (54%) | 421 (55%) | 139 (54%) | 138 (51%) | 55 (48%) | |
| DR3/X | 70 (14%) | 23 (9%) | 85 (11%) | 15 (6%) | 19 (7%) | 16 (14%) | |
| DRX/X | 42 (9%) | 45 (18%) | 112 (15%) | 9 (4%) | 10 (4%) | 2 (2%) | |
| Unknown | 0 (0%) | 1 (0%) | 3 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| Age of seroconversion | 5.38 ± .51 | 6.28 ± .64 | 6.93 ± .38 | 3.48 ± .41 | 2.52 ± .25 | 4.71 ± .59 | |
| Age of diagnosis | – | – | – | 7.64 ± .52 | 7.11 ± .54 | 10.46 ± .69 | |
Distribution of undiagnosed and diagnosed participants in three trajectories over sex and HLA-DR status; age (mean ± standard deviation) of seroconversion and diagnosis for undiagnosed and diagnosed participants.